Product Information
BACLOFEN 20 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0519 per EA under NDC 16571017210. Its NADAC has been published 113 times since Aug 7, 2024.
FDA first approved this application on Mar 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571017210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA214374FDA Approved
3/5/2021
TE Code
AB
On Market Since
3/1/2024
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 20 MG TABLET has been published 113 times since Aug 7, 2024, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0519 per EA |
|---|---|
| All-time high | $0.0691 (Sep 11, 2024) |
| All-time low | $0.0463 (Nov 20, 2024) |
| 52-week high | $0.0560 |
| 52-week low | $0.0509 |
| Median price | $0.0548 |
| Average price | $0.0550 |
| Largest weekly change | +29.3% (Aug 21, 2024) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BACLOFEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 20 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0519 per EA (NDC 16571017210), effective Sep 30, 2026.
How has the price of BACLOFEN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for BACLOFEN 20 MG TABLET has declined 3.0%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for BACLOFEN 20 MG TABLET?
Since Aug 7, 2024, the NADAC for BACLOFEN 20 MG TABLET has ranged from a low of $0.0463 (Nov 20, 2024) to a high of $0.0691 (Sep 11, 2024), with a median of $0.0548 per EA.
Are there cheaper alternatives to BACLOFEN 20 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 20 MG TABLET?
BACLOFEN 20 MG TABLET (NDC 16571017210) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.